An email lands with “FDA Inspection” in the subject line, and the plant manager’s first reaction is almost always: “we did nothing wrong — why us?” That is the biggest misunderstanding in the room. FDA does not need a reason to inspect a foreign facility: your plant is registered under FFR and your goods keep entering the US, so you are on the list. An inspection is not a punishment; it is routine. What actually decides the outcome is what you do between the notice and the knock on the door.
The four stages: from one email to one conclusion
An FDA foreign inspection generally runs through four stages:
- Notice: FDA coordinates dates with the factory in advance (foreign inspections are usually announced) — this window is your golden preparation period
- Opening meeting: the investigator states the scope and legal basis; the factory presents its process and quality architecture
- On-site audit: walking the line, pulling records, questioning staff — the constant theme is whether documents and reality reconcile
- Closing meeting: deficiencies may be issued on the spot as Form 483 observations, explained item by item to management
A 483 is not the end of the world, but the clock starts: the response window is 15 working days. The response must address each observation with corrective actions and evidence — not a one-line “we will improve.” Response quality feeds directly into the final classification: NAI (no action indicated), VAI (voluntary action indicated), or OAI (official action indicated). Land in OAI and what follows can be a warning letter, import restrictions, and goods that get a very different look at the port.
One red line up front: refusing an inspection can put your products straight onto an Import Alert — no examination needed, automatic detention at the port. Avoidance was never an option.
The preparation checklist for Taiwanese factories
From walking clients through this, preparation concentrates into four things:
- Record completeness: batch production records, cleaning and sanitation logs, and personnel training records are the three most-pulled items. The investigator’s logic is simple — you say you do it; where is the record? The day your records break is the day the observation stands
- HACCP / PCQI documents: the food safety plan must be producible, current-version, and match the actual process; be ready to answer specifically who your PCQI is and how they were trained
- Closure evidence for previous findings: if you were cited before, this investigator will check whether you closed it. Corrective action needs documents, photos, and follow-up monitoring records — “verbally improved” equals not improved
- Interpretation and escort: the audit runs in English; have someone who can translate process and QA terminology in real time, rehearse the escort route, and assign who answers what — do not let a line operator get ambushed mid-shift
How the inspection ties into your export chain
The result does not stay inside the factory. The classification feeds back into the clearance risk of every product you ship; your US importer will ask for the outcome during FSVP verification; and the batch records the investigator pulls are the same data set FSMA 204 traceability expects you to maintain every day. One record set serves three occasions — and one broken link fails all three at once.
How SKYCARGO takes it from there
SKYCARGO INC holds FDA and USDA agent status and can act as your Importer of Record and consignee. On inspections we help at both ends: upstream, we align FFR registration, Prior Notice and batch documents in the shipping document flow so your daily records and customs papers are one set; downstream, if a classification affects clearance, the same team faces the examinations and keeps shipments moving instead of stranded. Personal parcels belong with Shiptw consolidation.
Received an inspection notice — or want the gaps mapped before one arrives? Send us your product lines and current document list and we will reply within one business day with a suggested preparation order.
This article summarizes FDA inspection procedures for reference only. Actual processes follow FDA’s current publications and case-specific notices.
